Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):189-194. doi: 10.3760/cma.j.issn.1001-0939.2020.03.010.
Severe acute respiratory infection (SARI) diseases (such as SARS, MERS, pH1N1) can rapidly progress to acute respiratory failure with high lethality. The outbreak of a novel coronavirus infection can lead to 15%~ 30% patients developing into acute respiratory distress syndrome (ARDS). Respiratory support is the most important therapy for SARI patients with respiratory failure. However, respiratory support is a high skilled technology, which means inappropriate application may bring related complications and cross infection of SARI pathogens among medical staff and non-medical personnel in hospital. Therefore, it is meaningful to established a standardized indication of respiratory support and to prevent related nosocomial transmission in SARI patients.
严重急性呼吸道感染（SARI）疾病（如SARS、MERS、pH1N1）可迅速发展为急性呼吸衰竭，致死率高。新型冠状病毒感染的暴发可导致15%~30%的患者发展为急性呼吸窘迫综合征（ARDS）。呼吸支持是呼吸衰竭SARI患者最重要的治疗方法。然而，呼吸支持是一项高技能技术，这意味着不恰当的应用可能会带来相关并发症以及SARI病原体在医院医护人员和非医护人员之间的交叉感染。因此，确立呼吸支持的标准化指征并预防SARI患者相关的医院内传播具有重要意义。
